Activation of G protein by opioid receptors: Role of receptor number and G-protein concentration

European Journal of Pharmacology

Volumn 396, Issue 2-3, 2000, Pages 67-75

  Remmers, Ann E ^a   Clark, Mary J ^a   Alt, Andrew ^a   Medzihradsky, Fedor ^a   Woods, James H ^a   Traynor, John R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Opioid receptor; Opioid receptor; 35S GTP S binding; Collision coupling model; Compartmentalization; G protein

Indexed keywords

7 SPIROINDINOOXYMORPHONE; BETA FUNALTREXAMINE; CHLORNALTREXAMINE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MU OPIATE RECEPTOR; NALBUPHINE; NALOXONE; NALTRINDOLE; NALTRINDOLE 5' ISOTHIOCYANATE; OPIATE AGONIST; OPIATE RECEPTOR; PARTIAL AGONIST; PERTUSSIS TOXIN; SULFUR 35; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; GLIOMA CELL; HUMAN; HUMAN CELL; MODEL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RAT; RECEPTOR DENSITY;

ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; TUMOR CELLS, CULTURED;

EID: 0034685965     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00212-0     Document Type: Article

References (24)

1. 35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J. Biol. Chem. 273:1998;16865-16873.
2. 32P]GTP labeling of multiple G protein α subunits. J. Neurochem. 64:1995;2534-2543.
3. Clark M.J., Emmerson P.J., Mansour A.M., Akil H., Woods J.H., Portoghese P.S., Remmers A.E., Medzihradsky F. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. J. Pharmacol. Exp. Ther. 283:1997;501-510.
4. Connor M., Henderson G. Delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 117:1996;333-340.
5. Emmerson P.J., Clark M.J., Mansour M., Akil H., Woods J.H., Medzihradsky F. Characterization of opioid agonist efficacy in a C6 Glioma cell line expressing the μ opioid receptor. J. Pharmacol. Exp. Ther. 278:1996;1121-1127.
6. Ferguson K.M., Higashijima T., Smigel M.D., Gilman A.G. The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins. J. Biol. Chem. 261:1986;7393-7399.
7. Fischel S.V., Medzihradsky F. Scatchard analysis of opiate receptor binding. Mol. Pharmacol. 20:1981;269-279.
8. Florio V.A., Sternweis P.C. Mechanisms of muscarinic receptor action on Go in reconstituted phospholipid vesicles. J. Biol. Chem. 264:1989;3909-3915.
9. Graeser D., Neubig R.R. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors. Mol. Pharmacol. 43:1993;434-443.
10. Kasmi S.M., Misra R.K. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 32:1987;109-118.
11. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
12. Laugwitz K.-H., Offermanns S., Spicher K., Schultz G. Mu and delta opioid receptors differentially couple to G subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron. 10:1993;233-242.
13. Mukhopadhyay S., Ross E.M. Rapid GTP binding and hydrolysis by Gq promoted by receptor and GTPase-activating proteins. Proc. Natl. Acad. Sci. U. S. A. 96:1999;9539-9544.
14. Neubig R.R. Membrane organization in G-protein mechanisms. FASEB J. 8:1994;939-946.
15. Neubig R.R. Specificity of receptor-G protein coupling: protein structure and cellular determinants. Semin. Neurosci. 9:1998;189-197.
16. Neubig R.R., Gantzos R.D., Brasier R.S. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Mol. Pharmacol. 28:1985;475-486.
17. Olianas M.C., Onali P. Synergistic interaction of muscarinic and opioid receptors with Gs-linked neurotransmitter receptors to stimulate adenylyl cyclase activity of rat olfactory bulb. J. Neurochem. 61:1993;2183-2190.
18. Portoghese P.S., Moe S.T., Takemori A.E. A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists. J. Med. Chem. 36:1993;2572-2574.
19. Prather P.L., McGinn T.M., Erickson L.J., Loh H.H., Law P.Y. Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density. J. Biol. Chem. 269:1994;21293-21302.
20. Stickle D., Barber R. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model. Mol. Pharmacol. 43:1993;397-411.
21. Stickle D., Barber R. Collisions and encounters in simulations of receptor/GTP-binding protein interactions via simple diffusion. Biochim. Biophys. Acta. 1310:1996;242-250.
22. Tolkovsky A.M., Levitzki A. Mode of coupling between the β-adrenergic receptor and adenylate cyclase in turkey erythrocytes. Biochemistry. 17:1978;3795-3810.
23. 35S] thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47:1995;848-854.
24. Yu V.C., Sadee W. Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells. J. Pharmacol. Exp. Ther. 265:1988;254-262.